CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,253,250 | +89.1% | 534,923 | +117.5% | 0.00% | – |
| Q2 2023 | $3,306,160 | -61.8% | 245,994 | -52.8% | 0.00% | -100.0% |
| Q1 2023 | $8,645,028 | +279.9% | 521,413 | +326.2% | 0.00% | – |
| Q4 2022 | $2,275,654 | +138.0% | 122,347 | +64.2% | 0.00% | – |
| Q3 2022 | $956,000 | -40.8% | 74,500 | -67.7% | 0.00% | – |
| Q2 2022 | $1,615,000 | -16.5% | 230,349 | -1.3% | 0.00% | – |
| Q1 2022 | $1,934,000 | +35.8% | 233,312 | +10.9% | 0.00% | – |
| Q4 2021 | $1,424,000 | -11.6% | 210,383 | -30.7% | 0.00% | – |
| Q3 2021 | $1,610,000 | -11.9% | 303,659 | -4.5% | 0.00% | – |
| Q2 2021 | $1,828,000 | +248.9% | 317,943 | +180.0% | 0.00% | – |
| Q1 2021 | $524,000 | -38.0% | 113,537 | -55.1% | 0.00% | – |
| Q4 2020 | $845,000 | +16.1% | 252,937 | +3.3% | 0.00% | – |
| Q3 2020 | $728,000 | +398.6% | 244,789 | +677.1% | 0.00% | – |
| Q2 2020 | $146,000 | -95.9% | 31,500 | -96.6% | 0.00% | -100.0% |
| Q1 2020 | $3,557,000 | -23.0% | 924,112 | -25.0% | 0.00% | 0.0% |
| Q4 2019 | $4,620,000 | +601.1% | 1,232,261 | +894.3% | 0.00% | – |
| Q3 2019 | $659,000 | +29.2% | 123,938 | -6.7% | 0.00% | – |
| Q2 2019 | $510,000 | +152.5% | 132,878 | +236.2% | 0.00% | – |
| Q1 2019 | $202,000 | +47.4% | 39,519 | -44.5% | 0.00% | – |
| Q4 2018 | $137,000 | -39.1% | 71,194 | +19.7% | 0.00% | – |
| Q3 2018 | $225,000 | +411.4% | 59,468 | +323.2% | 0.00% | – |
| Q2 2018 | $44,000 | -81.8% | 14,051 | -86.2% | 0.00% | – |
| Q1 2018 | $242,000 | -59.8% | 101,453 | -34.1% | 0.00% | – |
| Q4 2017 | $602,000 | +600.0% | 153,834 | +350.6% | 0.00% | – |
| Q3 2017 | $86,000 | +32.3% | 34,137 | +46.6% | 0.00% | – |
| Q2 2017 | $65,000 | -12.2% | 23,287 | -63.2% | 0.00% | – |
| Q1 2016 | $74,000 | -83.1% | 63,270 | -64.6% | 0.00% | – |
| Q4 2015 | $437,000 | +2.6% | 178,634 | +25.6% | 0.00% | – |
| Q3 2015 | $426,000 | +29.5% | 142,223 | +78.3% | 0.00% | – |
| Q2 2015 | $329,000 | +115.0% | 79,761 | +126.0% | 0.00% | – |
| Q1 2015 | $153,000 | +35.4% | 35,298 | -7.8% | 0.00% | – |
| Q4 2014 | $113,000 | -58.9% | 38,297 | -53.8% | 0.00% | – |
| Q3 2014 | $275,000 | +400.0% | 82,919 | +284.3% | 0.00% | – |
| Q2 2014 | $55,000 | +223.5% | 21,578 | +184.0% | 0.00% | – |
| Q1 2014 | $17,000 | -55.3% | 7,599 | -61.0% | 0.00% | – |
| Q4 2013 | $38,000 | +153.3% | 19,470 | +15.5% | 0.00% | – |
| Q2 2013 | $15,000 | – | 16,861 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $2,458 | 7.14% |
| GABLES CAPITAL MANAGEMENT INC. | 409,080 | $6,782,546 | 4.74% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,355,099 | $171,687,541 | 3.83% |
| JW Asset Management, LLC | 563,392 | $9,341,039 | 3.58% |
| Quantedge Capital Pte Ltd | 324,700 | $5,383,526 | 2.10% |
| Paradiem, LLC | 236,628 | $3,923,292 | 1.22% |
| SummerHaven Investment Management, LLC | 100,592 | $1,667,815 | 0.97% |
| Capital Impact Advisors, LLC | 46,096 | $764,272 | 0.94% |
| Yorktown Management & Research Co Inc | 50,000 | $829,000 | 0.89% |
| Seaport Global Advisors, LLC | 15,598 | $258,615 | 0.82% |